Novelix Pharmaceuticals Ltd Share Price
₹47.50
+1.51
(+3.28%)
as on
Novelix Pharmaceuticals Ltd Stock Performance
as on October 21, 2025 at 4:01 pm IST
Day's Low
Day's High
₹46.18₹48.28
2.78%
Downside
1.64%
Upside
52 Week's Low
52 Week's High
₹21.91₹52.7953.87%
Downside
11.14%
Upside
Novelix Pharmaceuticals Ltd share price movements today
- Previous Close
- ₹45.99
- Open
- ₹48.28
- Volume
- 12.81K
- Upper Circuit
- ₹48.28
- Lower Circuit
- ₹43.70
- Day's Low - High
- ₹46.18 - ₹48.28
- 52 Week Low - High
- ₹21.91 - ₹52.79
Novelix Pharmaceuticals Ltd Historical Returns
- 1 Month Return
- + 18.5 %
- 3 Month Return
- + 7.95 %
- 1 Year Return
- + 116.29 %
- 3 Year Return
- + 398.84 %
- 5 Year Return
- + 724.17 %
Novelix Pharmaceuticals Ltd Fundamentals
as on October 21, 2025 at 4:01 pm IST
Market Cap
₹68.62 Cr
Return on Equity (ROE)
0.56
PE Ratio (TTM)
-17.3
Return on capital employed (ROCE)
0.84
Industry PE ratio
42.13
Beta (LTM)
0.34
P/B Ratio
1.51
Dividend Yield
0PEG Ratio
-12.72
Quarterly Earnings Growth YOY
-142.86
EPS (TTM)
-2.5
Sector
Pharmaceuticals
Book Value
9.14
Technical Analysis
Bullish
View Technical Analysis
Novelix Pharmaceuticals Ltd Stock Valuation
as on October 21, 2025 at 4:01 pm IST
Novelix Pharmaceuticals Ltd in the last 5 years
Lowest (-38.24x)
January 31, 2018
Today (-17.30x)
October 21, 2025
Industry (42.13x)
October 21, 2025
Highest (-1.18x)
September 29, 2021
Today’s Price to Earnings Ratio: -17.30x
Novelix Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Novelix Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 68.62 | 144.83% | 0.00 | -3 | 8 | |
| NA | 177.68 | 6.15% | 0.00 | 24 | 115 | |
| NA | 8.30 | 57.14% | 0.00 | -1 | 1 | |
| NA | 21.02 | 6.8% | 0.00 | NA | 51 | |
| NA | 773.10 | 116.32% | 0.88 | 30 | 599 |
Novelix Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest
Search interest for Novelix Pharmaceuticals Ltd Stock has increased by 68% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:68% versus previous 30 day period
Novelix Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Novelix Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Novelix Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Novelix Pharmaceuticals Ltd Corporate Actions
View detailed summary of the earnings and dividend history of Novelix Pharmaceuticals Ltd.
Novelix Pharmaceuticals Ltd Earnings Results
Novelix Pharmaceuticals Ltd’s net profit fell -140.63% since last year same period to ₹0.13Cr in the Q2 2022-2023. On a quarterly growth basis, Novelix Pharmaceuticals Ltd has generated -85.71% fall in its net profits since last 3-months.
Read More about Earnings ResultsNovelix Pharmaceuticals Ltd Dividends July,2012
In the quarter ending June 2012, Novelix Pharmaceuticals Ltd has declared dividend of ₹0.30 per share on 23 Jul 2012 - translating a dividend yield of 1.26%.
Read More about Dividends
Insights on Novelix Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers
- POSITIVE IMPACT
Price Rise
In the last 7 days, Novelix Pharma. stock has moved up by 18.2%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, Novelix Pharma. has outperformed top 5 stocks with highest market-cap in Drug Retailers
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 33.44% to 47.25% in Jun 2025 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -0.07 Cr → -0.13 Cr (in ₹), with an average decrease of 85.7% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 66.56% to 52.75% in Jun 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.43 Cr → 1.3 Cr (in ₹), with an average decrease of 9.1% per quarter
About Novelix Pharmaceuticals Ltd
Revenue: ₹1.24Cr as on September 2022 (Q2 FY23)
Net Profit: ₹0.15Cr as on September 2022 (Q2 FY23)
| Organisation | Novelix Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs
What is Novelix Pharmaceuticals Ltd share price today?
Novelix Pharmaceuticals Ltd share price today stands at ₹47.5 as on at the close of the market. Novelix Pharmaceuticals Ltd share today touched a day high of ₹48.28 and a low of ₹46.18.
What is the 52 week high and 52 week low range for Novelix Pharmaceuticals Ltd share?
Novelix Pharmaceuticals Ltd touched a 52 week high of ₹52.79 and a 52 week low of ₹21.91. Novelix Pharmaceuticals Ltd share price today i.e. is closed at ₹47.5, which is -10.02% down from its 52 week high and 116.80% up from its 52 week low.
What is Novelix Pharmaceuticals Ltd's market capitalisation today?
Novelix Pharmaceuticals Ltd market capitalisation is ₹68.62 Cr as on .
How to buy Novelix Pharmaceuticals Ltd shares?
To buy Novelix Pharmaceuticals Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 536565 or Novelix Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Novelix Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Novelix Pharmaceuticals Ltd trading volume today?
Novelix Pharmaceuticals Ltd trading volume is 12.81K as on . This means that 12.81K shares of Novelix Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.